Cargando…
Hepatocyte growth factor is a potential biomarker for osteoproliferation and osteoporosis in ankylosing spondylitis
SUMMARY: We explored relations between serum hepatocyte growth factor (HGF), disease activity, osteoproliferation, and bone mineral density (BMD) in ankylosing spondylitis (AS), in comparison with healthy controls. HGF was increased especially in male AS patients and smokers and associated with both...
Autores principales: | Torres, L., Klingberg, E., Nurkkala, M., Carlsten, H., Forsblad-d’Elia, H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449322/ https://www.ncbi.nlm.nih.gov/pubmed/30306221 http://dx.doi.org/10.1007/s00198-018-4721-4 |
Ejemplares similares
-
Elevated serum level of hepatocyte growth factor predicts development of new syndesmophytes in men with ankylosing spondylitis
por: Deminger, Anna, et al.
Publicado: (2020) -
Osteoporosis in ankylosing spondylitis - prevalence, risk factors and methods of assessment
por: Klingberg, Eva, et al.
Publicado: (2012) -
Cardiac conduction system abnormalities in ankylosing spondylitis: a cross-sectional study
por: Forsblad-d’Elia, Helena, et al.
Publicado: (2013) -
A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis
por: Klingberg, Eva, et al.
Publicado: (2017) -
Factors associated with changes in volumetric bone mineral density and cortical area in men with ankylosing spondylitis: a 5-year prospective study using HRpQCT.
por: Deminger, A., et al.
Publicado: (2021)